Citigroup’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,591,334
| Closed | -$74.8M | – | 6317 |
|
|
2025
Q2 | $74.8M | Buy |
1,591,334
+1,449,188
| +1,020% | +$64.5M | 0.04% | 445 |
|
|
2025
Q1 | $6.27M | Buy |
142,146
+27,081
| +24% | +$1.25M | ﹤0.01% | 1704 |
|
|
2024
Q4 | $4.16M | Buy |
115,065
+59,540
| +107% | +$2.08M | ﹤0.01% | 2156 |
|
|
2024
Q3 | $1.78M | Buy |
55,525
+20,030
| +56% | +$748K | ﹤0.01% | 2774 |
|
|
2024
Q2 | $1.34M | Sell |
35,495
-128,050
| -78% | -$5.39M | ﹤0.01% | 2677 |
|
|
2024
Q1 | $8.05M | Buy |
163,545
+83,769
| +105% | +$3.87M | 0.01% | 1378 |
|
|
2023
Q4 | $2.91M | Buy |
79,776
+314
| +0.4% | +$8.2K | ﹤0.01% | 1959 |
|
|
2023
Q3 | $1.84M | Sell |
79,462
-8,458
| -10% | -$231K | ﹤0.01% | 2056 |
|
|
2023
Q2 | $2.31M | Sell |
87,920
-92,522
| -51% | -$2.43M | ﹤0.01% | 2073 |
|
|
2023
Q1 | $4.64M | Buy |
180,442
+39,428
| +28% | +$1.15M | ﹤0.01% | 1541 |
|
|
2022
Q4 | $3.67M | Sell |
141,014
-83,416
| -37% | -$2.06M | ﹤0.01% | 1646 |
|
|
2022
Q3 | $6.4M | Sell |
224,430
-29,632
| -12% | -$850K | ﹤0.01% | 1404 |
|
|
2022
Q2 | $6.25M | Buy |
254,062
+234,558
| +1,203% | +$8.58M | ﹤0.01% | 1403 |
|
|
2022
Q1 | $1.1M | Sell |
19,504
-48,214
| -71% | -$2.76M | ﹤0.01% | 2879 |
|
|
2021
Q4 | $4.2M | Buy |
67,718
+29,692
| +78% | +$1.96M | ﹤0.01% | 1965 |
|
|
2021
Q3 | $2.41M | Sell |
38,026
-16,720
| -31% | -$1.29M | ﹤0.01% | 2385 |
|
|
2021
Q2 | $4.51M | Sell |
54,746
-1,942
| -3% | -$147K | ﹤0.01% | 1983 |
|
|
2021
Q1 | $4.17M | Buy |
56,688
+43,690
| +336% | +$3.42M | ﹤0.01% | 1912 |
|
|
2020
Q4 | $943K | Buy |
12,998
+9,483
| +270% | +$610K | ﹤0.01% | 3598 |
|
|
2020
Q3 | $167K | Sell |
3,515
-3,845
| -52% | -$164K | ﹤0.01% | 4749 |
|
|
2020
Q2 | $309K | Buy |
7,360
+3,062
| +71% | +$109K | ﹤0.01% | 4677 |
|
|
2020
Q1 | $116K | Buy |
4,298
+2,204
| +105% | +$71.9K | ﹤0.01% | 5223 |
|
|
2019
Q4 | $81K | Buy |
+2,094
| New | +$49K | ﹤0.01% | 5947 |
|
Other funds holding SWTX
Citigroup's SWTX Position: Q3 2025 in Review
Citigroup sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 1,591,334 shares — an estimated $74.8M sold.
Citigroup first reported a position in SWTX in Q4 2019 and held it in 23 quarters. The position peaked at $74.8M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- Citigroup reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- Citigroup sold 1,591,334 SpringWorks Therapeutics shares in Q3 2025, an estimated $74.8M.
- Citigroup first reported a position in SpringWorks Therapeutics in Q4 2019 and held it in 23 quarters.
- Citigroup's SpringWorks Therapeutics position peaked at $74.8M in Q2 2025.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on Citigroup's 13F filing for Q3 2025, filed 10 Nov 2025.